Literature DB >> 25275025

Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.

Takahito Kitajima1, Yuji Toiyama2, Koji Tanaka1, Susumu Saigusa1, Minako Kobayashi1, Yasuhiro Inoue1, Yasuhiko Mohri1, Masato Kusunoki1.   

Abstract

BACKGROUND: Vasohibin-1 (VASH1) is related to angiogenesis and poor prognosis in several types of cancers. However, the biological function and clinical significance of VASH1 in colorectal cancer (CRC) are not fully known.
MATERIALS AND METHODS: The associations between VASH1 expression and clinicopathological features were investigated by immunohistochemistry in 429 CRC tissues. To evaluate the function of VASH1 in vitro, small-interfering VASH1-targeting RNA was transfected into human CRC cell lines.
RESULTS: We found that VASH1 was highly expressed in the cytoplasm of CRC tissues. High VASH1 expression in the cytoplasm was significantly associated with tumor progression, such as larger tumor size, advanced T-stage, lymph node metastasis, distant metastasis and poor prognosis. Moreover, a significant positive correlation was detected between VASH1 expression and microvessel density. VASH1 siRNA inhibited CRC cell proliferation, migration, and invasion, and promoted anoikis.
CONCLUSION: Overexpression of VASH1 in CRC cells increased malignant potential and promoted metastasis. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Colorectal cancer; angiogenesis; vasohibin-1

Mesh:

Substances:

Year:  2014        PMID: 25275025

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Vasohibin 1 inhibits Adriamycin resistance in osteosarcoma cells via the protein kinase B signaling pathway.

Authors:  Wei Huang; Yangguang Ren; Hui Liu
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

2.  Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus.

Authors:  Yamato Ninomiya; Soji Ozawa; Junya Oguma; Akihito Kazuno; Miho Nitta; Hiroshi Kajiwara; Yasufumi Sato
Journal:  Oncol Lett       Date:  2018-08-01       Impact factor: 2.967

3.  Vasohibin 2 as a potential predictor of aggressive behavior of triple-negative breast cancer.

Authors:  Bin Wang; Liang Yang; Qian Zhao; Liping Zhu
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

4.  The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.

Authors:  Zhanlong Shen; Yichao Yan; Chunxiang Ye; Bo Wang; Kewei Jiang; Yingjiang Ye; Harri Mustonen; Pauli Puolakkainen; Shan Wang
Journal:  Tumour Biol       Date:  2015-12-14

5.  Vasohibin-1 suppresses colon cancer.

Authors:  Shuai Liu; Bing Han; Qunyuan Zhang; Jie Dou; Fang Wang; Wenli Lin; Yuping Sun; Guangyong Peng
Journal:  Oncotarget       Date:  2015-04-10

6.  Vasohibin-1 rescues erectile function through up-regulation of angiogenic factors in the diabetic mice.

Authors:  Kang-Moon Song; Woo Jean Kim; Min-Ji Choi; Ki-Dong Kwon; Anita Limanjaya; Kalyan Ghatak; Jiyeon Ock; Guo Nan Yin; Yasufumi Sato; Soon-Sun Hong; Ji-Kan Ryu; Jun-Kyu Suh
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

7.  Assessment of the Concentration of Endogenous Factors Regulating Angiogenesis, VASH-1 and VEGF-A, in the Blood Serum of Patients with Neuroendocrine Neoplasms.

Authors:  Janusz Strzelczyk; Monika Wójcik-Giertuga; Piotr Cuber; Krzysztof Biernacki; Beata Kos-Kudła; Joanna Katarzyna Strzelczyk
Journal:  Biomed Res Int       Date:  2022-03-10       Impact factor: 3.411

Review 8.  Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression.

Authors:  Katsuyuki Tanabe; Yasufumi Sato; Jun Wada
Journal:  Int J Mol Sci       Date:  2018-06-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.